DD211567A5 - Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen - Google Patents

Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen Download PDF

Info

Publication number
DD211567A5
DD211567A5 DD82242677A DD24267782A DD211567A5 DD 211567 A5 DD211567 A5 DD 211567A5 DD 82242677 A DD82242677 A DD 82242677A DD 24267782 A DD24267782 A DD 24267782A DD 211567 A5 DD211567 A5 DD 211567A5
Authority
DD
German Democratic Republic
Prior art keywords
chloroform
mixture
fluoro
dien
solution
Prior art date
Application number
DD82242677A
Other languages
German (de)
English (en)
Inventor
Ravi K Varma
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DD211567A5 publication Critical patent/DD211567A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DD82242677A 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen DD211567A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/294,680 US4361559A (en) 1981-08-20 1981-08-20 Antiinflammatory 17,17-bis (substituted thio) androstenes

Publications (1)

Publication Number Publication Date
DD211567A5 true DD211567A5 (de) 1984-07-18

Family

ID=23134474

Family Applications (3)

Application Number Title Priority Date Filing Date
DD82257409A DD215086A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82257403A DD215556A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82242677A DD211567A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DD82257409A DD215086A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82257403A DD215556A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen

Country Status (24)

Country Link
US (1) US4361559A (da)
EP (1) EP0073026B1 (da)
JP (1) JPS5841900A (da)
KR (1) KR890000678B1 (da)
AT (1) ATE18671T1 (da)
AU (1) AU564228B2 (da)
CA (1) CA1213270A (da)
CS (1) CS235959B2 (da)
DD (3) DD215086A5 (da)
DE (1) DE3269987D1 (da)
DK (1) DK165838C (da)
ES (3) ES8308336A1 (da)
FI (1) FI78916C (da)
GR (1) GR76251B (da)
HU (1) HU187783B (da)
IE (1) IE53732B1 (da)
IL (1) IL66564A (da)
NO (1) NO159601C (da)
NZ (1) NZ201343A (da)
PH (2) PH18594A (da)
PL (2) PL141303B1 (da)
PT (1) PT75442B (da)
SU (1) SU1189353A3 (da)
ZA (1) ZA825260B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447363A (en) * 1982-07-07 1984-05-08 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4435326A (en) * 1982-09-09 1984-03-06 E. R. Squibb & Sons, Inc. Intermediates useful in the preparation of 17,17-bis(substituted thio)androstenes
US4420428A (en) * 1982-12-27 1983-12-13 E. R. Squibb & Sons, Inc. 16-Ketoandrostene-17-dithioketals
US4427592A (en) * 1983-01-31 1984-01-24 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4499021A (en) * 1984-04-12 1985-02-12 E. R. Squibb & Sons, Inc. 17β(Substituted thio)-16-ketoandrostene-17α..-carboxylic acid derivatives
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
US4529547A (en) * 1984-06-20 1985-07-16 E.R. Squibb & Sons, Inc. 17-(substituted thio)-17-(substituted dithio)androstenes
US4528138A (en) * 1984-06-20 1985-07-09 E. R. Squibb & Sons, Inc. 16-Keto-17-substituted thia-17-alkyl(or alkenyl or alkynyl) androstenes
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4868168A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid ointment formulation
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US5016635A (en) * 1988-11-29 1991-05-21 Sigmedics, Inc. Of Delaware Control of FNS via pattern variations of response EMG
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
IE922301A1 (en) * 1991-07-25 1993-01-27 Squibb & Sons Inc Selective thioketalization process, process for preparing¹thioenol ethers from thioketals, and process for the¹preparation of thioketals
IL108167A0 (en) * 1992-12-24 1994-04-12 Rhone Poulenc Rorer Ltd Steroids, their preparation and pharmaceutical compositions containing them
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840577A (en) * 1956-12-21 1958-06-24 Searle & Co 17-thio derivatives of estratrien-3-ol and of estratetraen-3-ol
US2949477A (en) * 1959-03-04 1960-08-16 Searle & Co 1, 3, 17-triacetoxyestra-1, 3, 5(10), 16-tetraene and congeners
US4091036A (en) * 1977-05-12 1978-05-23 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio)-1',2',3',4'-tetrahydroandrosteno [16 α, 17 α-b]naphthalenes and derivatives
US4094840A (en) * 1977-05-12 1978-06-13 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio) androsteno[16α,17α-b]benzodioxin-3-ones
US4133811A (en) * 1978-02-17 1979-01-09 E. R. Squibb & Sons, Inc. 13-Alkylthio (and arylthio)-11,17-epoxy-17-methyl-18-norandrostenes
US4146538A (en) * 1978-02-27 1979-03-27 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio) androsteno[17α,16α-b]benzopyran-3-ones and [16α,17α]naphthopyran-3-ones

Also Published As

Publication number Publication date
PL244113A1 (en) 1984-05-21
FI822890A0 (fi) 1982-08-19
AU8631882A (en) 1983-02-24
FI78916C (fi) 1989-10-10
CS235959B2 (en) 1985-05-15
JPH035400B2 (da) 1991-01-25
IE821951L (en) 1983-02-20
ATE18671T1 (de) 1986-04-15
IL66564A0 (en) 1982-12-31
ES8406506A1 (es) 1984-07-01
PL237936A1 (en) 1984-02-13
HU187783B (en) 1986-02-28
DK165838B (da) 1993-01-25
ZA825260B (en) 1983-05-25
FI78916B (fi) 1989-06-30
IL66564A (en) 1986-03-31
DE3269987D1 (en) 1986-04-24
GR76251B (da) 1984-08-04
JPS5841900A (ja) 1983-03-11
FI822890L (fi) 1983-02-21
IE53732B1 (en) 1989-02-01
DK165838C (da) 1993-06-21
NZ201343A (en) 1985-08-16
EP0073026A1 (en) 1983-03-02
CA1213270A (en) 1986-10-28
PH18594A (en) 1985-08-12
ES515110A0 (es) 1983-08-16
ES521952A0 (es) 1984-07-01
PT75442B (en) 1985-01-04
US4361559A (en) 1982-11-30
DK372982A (da) 1983-02-21
ES8308336A1 (es) 1983-08-16
PT75442A (en) 1982-09-01
KR890000678B1 (ko) 1989-03-24
EP0073026B1 (en) 1986-03-19
DD215556A5 (de) 1984-11-14
SU1189353A3 (ru) 1985-10-30
NO822823L (no) 1983-02-21
AU564228B2 (en) 1987-08-06
PH19857A (en) 1986-07-22
ES8406505A1 (es) 1984-07-01
KR840001183A (ko) 1984-03-28
DD215086A5 (de) 1984-10-31
NO159601B (no) 1988-10-10
PL141303B1 (en) 1987-07-31
ES521951A0 (es) 1984-07-01
NO159601C (no) 1989-01-18

Similar Documents

Publication Publication Date Title
DD211567A5 (de) Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
EP0004975B1 (de) Corticoid-17-Alkylcarbonate, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel gegen Dermatosen
CH668599A5 (de) Substituierte androsta-1,4-dien-3,17-dione und verfahren zu deren herstellung.
Kertesz et al. Thiol esters from steroid 17. beta.-carboxylic acids: carboxylate activation and internal participation by 17. alpha.-acylates
DE2340591A1 (de) Steroidverbindungen
DE2906017A1 (de) 13-alkyl(oder aryl)-thio-11,17-epoxy- 17-methyl-18-norandrostene und verfahren zu ihrer herstellung
DE2907539A1 (de) 17-alkylthio-(und arylthio)-androsteno eckige klammer auf 17 alpha , 16 alpha -b eckige klammer zu benzopyran- 3-one und - eckige klammer auf 16 alpha , 17 alpha -b eckige klammer zu naphthopyran-3-one sowie deren verwendung als entzuendungshemmende wirkstoffe
DE3102397A1 (de) 17(alpha)-acyloxy-5(beta)-corticoide und 17(alpha)-acyloxy-5(alpha)-corticoide
DE69215125T2 (de) Kardioaktive Steroide
CH632279A5 (en) Process for the preparation of polyhalogenated steroids
US4011316A (en) Cyclohexa-2,5-diene-1-thiones
DE2550458A1 (de) 9,11 beta-dihalogen- eckige klammer auf 16 alpha, 17-b eckige klammer zu -1,4-dioxan-steroide der pregnanreihe
DE3324403A1 (de) Androsten-17-dithioketale und diese verbindungen enthaltende arzeimittel
US4427592A (en) Androstene-17-dithioketals
DE2309328A1 (de) 3-keto-7(alpha,beta)-nied.-alkyldelta hoch 5-steroide und verfahren zu ihrer herstellung
DE2149798A1 (de) Steroide der Pregnanreihe und Verfahren zu ihrer Herstellung
DE2436747A1 (de) Verfahren zur herstellung von 21-chlor17-acyloxy-3,20-diketopregnenen
DE2362280A1 (de) 21-sulfinylsteroide der delta hoch 4pregnanreihe, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US3347854A (en) Preparation of 11beta-hydroxy-19-nor steroidal-delta1, 3, 5 (10), 6, 8-pentaenes
DE1493178C3 (de) 6 alpha-Fluor-16 alpha-methyl-1,4pregnadien-3,20-dion-derivate und Verfahren zu ihrer Herstellung
AT220764B (de) Verfahren zur Herstellung von neuen 3-Oxo-Δ<1,4>-6-methyl- und 3-Oxo-Δ<1,4,6>-6-methylsteroiden
EP0469275A2 (de) 3-(oxo)- oder 3-(hydroxy)-substituierte 17 Alpha, 20-(Epoxy)-pregnan-20-carbonsäure-beziehungsweise-isocyanat-Derivate, ihre Verwendung und Verfahren zur Herstellung von 3-(oxo)- oder 3-(hydroxy)-substituierten 17 Alpha-(Hydroxy)-20-(oxo)-pregnan-Derivaten und der ersteren
DE881945C (de) Verfahren zur Herstellung therapeutisch wertvoller Alkohole der Cyclopentanopolyhydrophenanthrenreihe
DE1493344B1 (de) Verfahren zur Herstellung von 16 alpha-Chlor- oder -Fluor-17(20)-pregnen-21-saeureestern und daraus erhaeltlichen 16 alpha-Chlor- oder -Fluor-17 alpha-hydroxy-20-keto-21-acyloxyverbindungen der Pregnanreihe
DE2820635A1 (de) Steroid-16alpha,17alpha-benzodioxine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee